JOA - 2026-10-23 - Journal Article
Custom Triflange Acetabular Components in Revision Total Hip Arthroplasty: Survivorship, Clinical Outcomes and Risk Factors for Failure.
Kayani B, Drummond I, Merchant AA, Donaldson J, Stammers JG, Sabah SA, Skinner JA
Topics
Key Takeaway
Custom triflange acetabular components achieved 94.3% survivorship free from aseptic loosening at mean 44.8 months, with >4 prior hip operations and >2/3 ischial osteolysis identified as independent risk factors for radiographic failure.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study evaluated survivorship, functional outcomes, and failure risk factors for custom triflange acetabular components (CTAC) in 56 non-oncological revision THA patients with advanced acetabular bone defects. CTAC survivorship free from aseptic loosening was 94.3% (95% CI 82.6–98.2%) at mean 44.8 months; five components were revised (three aseptic loosening, two PJI). Median OHS improved from 12 to 36 (P<0.001), radiographic osseointegration was confirmed in 75% of patients, and risk factors for radiographic failure were >4 prior hip operations and >2/3 ischial osteolysis (both P<0.001).
Key Limitation
Small single-center cohort (n=56) with mid-term follow-up of under 4 years is insufficient to capture late aseptic loosening events, which are the primary failure mode for cementless acetabular reconstruction.
Original Abstract
BACKGROUND
The objectives of this study were to assess survivorship, functional outcomes, radiographic osseointegration, complications, and risk factors for failure in revision total hip arthroplasty (THA) with custom triflange acetabular components (CTAC) at mid-term follow-up.
METHODS
This study included 56 non-oncological patients who had advanced acetabular bone defects undergoing revision THAs using CTACs. Implant survivorship, the Oxford Hip Score (OHS), the Harris Hip Score (HHS), the University of California at Los Angeles (UCLA) activity score, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Forgotten Joint (FJS) Score, plain radiographic evidence of osseointegration, and any complications were recorded at the most recent follow-up. The mean follow-up time was 44.8 months (range, 13.7 to 63.4).
RESULTS
Survivorship of the CTAC was 94.3% (95% confidence interval (CI): 82.6 to 98.2) with CTAC revision for aseptic loosening as the end point. In total, five CTACs were revised: three for aseptic loosening and two for prosthetic joint infections. The median OHS improved from 12 (interquartile range(IQR), 10 to 14) preoperatively to 36 (IQR, 34 to 38) at final follow-up (P < 0.001). The median HHS was 64 (IQR, 60 to 72), the median UCLA score was 6 (IQR, 5 to 7), the median WOMAC score was 34 (IQR, 40 to 26), and the median FJS was 28 (IQR, 22 to 34) at final follow-up. Radiographic osseointegration at the bone-implant interface was observed in 42 patients (75.0%). Risk factors for radiographic failure included more than four previous hip operations (P < 0.001) and greater than two-thirds of ischial osteolysis (P < 0.001).
DISCUSSION
The reconstruction of advanced acetabular bone defects with CTACs is associated with excellent component survivorship, low risk of aseptic loosening, satisfactory functional outcomes, and good radiographic evidence of osseointegration. Multiple previous hip operations and extensive ischial osteolysis were associated with increased risk of radiographic failure.